Side-by-side comparison of AI visibility scores, market position, and capabilities
Tech-enabled NYC pharmacy with same-day prescription delivery; proactive pharmacist service and seamless insurance management for consumers prioritizing convenience.
Capsule is a tech-enabled online pharmacy providing prescription delivery in New York City, with a focus on superior customer experience — free same-day delivery, a clean app interface, automatic refill management, and proactive pharmacist communication that traditional chain pharmacies cannot match. Founded in 2016 and headquartered in New York City, Capsule raised over $300 million in funding from investors including Thrive Capital and has built a model that treats the pharmacy as a healthcare touchpoint rather than a retail transaction.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.